Published in Gut on October 01, 2004
Synbiotic Treatment in Crohn's Disease Patients | NCT00305409
Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology (2008) 3.79
Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis. Gut (2008) 1.75
How expensive is inflammatory bowel disease? A critical analysis. World J Gastroenterol (2008) 1.15
Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol (2013) 1.07
Quality of care delivered to hospitalized inflammatory bowel disease patients. World J Gastroenterol (2013) 1.02
Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease. Therap Adv Gastroenterol (2011) 0.99
Medical management of Crohn's disease. BMJ (2008) 0.97
Current practice and perception of screening for medication adherence in inflammatory bowel disease. J Clin Gastroenterol (2011) 0.96
Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it? World J Gastroenterol (2009) 0.94
An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J (2014) 0.92
Mesalazine in inflammatory bowel disease: a trendy topic once again? Can J Gastroenterol (2010) 0.92
The pharmacoeconomics of biologic therapy for IBD. Nat Rev Gastroenterol Hepatol (2010) 0.90
Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe. World J Gastroenterol (2015) 0.90
The impact of biologics on health-related quality of life in patients with inflammatory bowel disease. Clin Exp Gastroenterol (2009) 0.89
The economic and quality-of-life burden of Crohn's disease in Europe and the United States, 2000 to 2013: a systematic review. Dig Dis Sci (2014) 0.89
Hematopoietic cell transplantation for Crohn's disease; is it time? World J Gastroenterol (2006) 0.87
Long-term direct costs before and after proctocolectomy for ulcerative colitis: a population-based study in Olmsted County, Minnesota. Dis Colon Rectum (2009) 0.86
Knowledge of disease and health information needs of the patients with inflammatory bowel disease in a developing country. Int J Colorectal Dis (2005) 0.85
Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn's disease patients. Med Sci Monit (2013) 0.84
Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up. PLoS One (2016) 0.83
Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitis. Inflamm Bowel Dis (2013) 0.83
Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade. Gastroenterol Res Pract (2013) 0.83
Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnaire. Gut (2013) 0.83
Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach. Eur J Health Econ (2015) 0.83
Effect of a continuous measure of adherence with infliximab maintenance treatment on inpatient outcomes in Crohn's disease. Patient Prefer Adherence (2012) 0.82
Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database. BMC Gastroenterol (2013) 0.81
Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders--an evaluation study. BMC Health Serv Res (2009) 0.80
Adherence in ulcerative colitis: an overview. Patient Prefer Adherence (2017) 0.79
A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease. Clin Exp Gastroenterol (2016) 0.78
A medicoeconomic review of early intervention with biologic agents in the treatment of inflammatory bowel diseases. Clinicoecon Outcomes Res (2014) 0.78
Indirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic review. Arch Med Sci (2016) 0.78
Optimizing use of 5-ASA in the treatment of ulcerative colitis: Focus on patient compliance and adherence. Patient Relat Outcome Meas (2010) 0.77
Imaging choices in inflammatory bowel disease. Pediatr Radiol (2009) 0.77
Inflammatory Bowel Disease Drugs: A Focus on Autophagy. J Crohns Colitis (2016) 0.76
Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther (2016) 0.76
Maintaining remission in ulcerative colitis--role of once daily extended-release mesalamine. Drug Des Devel Ther (2011) 0.76
Cost-effectiveness of Crohn's disease post-operative care. World J Gastroenterol (2016) 0.75
Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis. Inflamm Bowel Dis (2015) 0.75
Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications. Appl Health Econ Health Policy (2017) 0.75
Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis. Clin Exp Gastroenterol (2017) 0.75
Over-reaching beyond disease activity: the influence of anxiety and medical economic burden on health-related quality of life in patients with inflammatory bowel disease. Patient Prefer Adherence (2016) 0.75
Costs in inflammatory bowel diseases. Prz Gastroenterol (2016) 0.75
Aligning oral mesalazine treatment to health service priorities: guidance for nurses. Frontline Gastroenterol (2013) 0.75
Appropriateness of laboratory testing in inflammatory bowel disease inpatients: an opportunity to reduce unnecessary healthcare costs. Dig Dis Sci (2013) 0.75
Cost of Illness in Inflammatory Bowel Disease. Dig Dis Sci (2017) 0.75
Open access follow up for inflammatory bowel disease: pragmatic randomised trial and cost effectiveness study. BMJ (2000) 3.12
Work losses related to inflammatory bowel disease in Canada: results from a National Population Health Survey. Am J Gastroenterol (2003) 2.63
Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial. Lancet (2001) 2.40
Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastroenterol (2000) 2.01
Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther (2000) 1.84
Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol (2003) 1.80
Annual cost of care for Crohn's disease: a payor perspective. Am J Gastroenterol (2000) 1.74
Inflammatory bowel disease incidence: up, down or unchanged? Gut (1998) 1.62
Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology (1999) 1.61
Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol (1992) 1.54
Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol (2003) 1.38
The cost of hospitalization in Crohn's disease. Am J Gastroenterol (2000) 1.27
A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based self-help guidebook and patient-centred consultations on disease management and satisfaction in inflammatory bowel disease. Health Technol Assess (2003) 1.18
Inflammatory bowel diseases: health care and costs in Sweden in 1994. Scand J Gastroenterol (1997) 1.17
Evaluation of the effectiveness of a specialist nurse in the management of inflammatory bowel disease (IBD). Eur J Gastroenterol Hepatol (2000) 1.17
Cost of illness of Crohn's disease. Pharmacoeconomics (2002) 1.09
Inflammatory bowel disease: medical cost algorithms. J Clin Gastroenterol (1992) 1.04
Crohn's disease and ulcerative colitis in England and the Oxford record linkage study area: a profile of hospitalized morbidity. Int J Epidemiol (1995) 1.00
The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis (2002) 0.94
Clinical economics review: medical management of inflammatory bowel disease. Aliment Pharmacol Ther (1999) 0.91
[Cost measurement based on a cost diary in patients with inflammatory bowel disease]. Z Gastroenterol (2002) 0.88
Patients consulting with Crohn's disease in primary care in England and Wales. Eur J Gastroenterol Hepatol (1998) 0.84
Effects of treatment for intestinal helminth infection on growth and cognitive performance in children: systematic review of randomised trials. BMJ (2000) 7.30
A new method for the quantitative investigation of cutaneous bacteria. J Invest Dermatol (1965) 5.71
Distribution of NHS funds between fundholding and non-fundholding practices. BMJ (1994) 4.05
HIV and male circumcision--a systematic review with assessment of the quality of studies. Lancet Infect Dis (2005) 3.49
Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med (1995) 3.48
Binding of -bungarotoxin to acetylcholine receptors in mammalian muscle (snake venom-denervated muscle-neonatal muscle-rat diaphragm-SDS-polyacrylamide gel electrophoresis). Proc Natl Acad Sci U S A (1972) 3.34
A subfamily of P-type ATPases with aminophospholipid transporting activity. Science (1996) 2.90
Functional organization of human supplementary motor cortex studied by electrical stimulation. J Neurosci (1991) 2.41
Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2003) 2.32
Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl (2007) 2.12
National Confidential Enquiry into counselling for genetic disorders by non-geneticists: general recommendations and specific standards for improving care. Br J Obstet Gynaecol (1999) 2.06
Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev (2010) 1.99
The physician and pharmacist team. An effective approach to cholesterol reduction. J Gen Intern Med (1997) 1.84
Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med (1999) 1.82
Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med (1998) 1.81
Prognostic factors for overall survival in patients with advanced ovarian carcinoma. Ann Oncol (1991) 1.77
Phosphatidylserine, a death knell. Cell Death Differ (2001) 1.74
Substance abuse during pregnancy: effect on pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol (2010) 1.66
Who is the patient? A family case study of a recurrent dilemma in family practice. J Fam Pract (1983) 1.63
Nocturnal cortisol, thyroid stimulating hormone, and growth hormone secretory profiles in depressed adolescents. J Am Acad Child Adolesc Psychiatry (1991) 1.60
A scale to measure physician beliefs about psychosocial aspects of patient care. Soc Sci Med (1984) 1.57
Predictive value of alarm features in a rapid access upper gastrointestinal cancer service. Gut (2005) 1.56
Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ (1999) 1.54
Confidential inquiry into families with two siblings with cystic fibrosis. Arch Dis Child (1997) 1.54
Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. Proc Natl Acad Sci U S A (1986) 1.53
Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder. Acta Psychiatr Scand (2011) 1.47
Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia. Clin Pharmacol Ther (2007) 1.47
Amnioinfusion in very early preterm prelabor rupture of membranes (AMIPROM): pregnancy, neonatal and maternal outcomes in a randomized controlled pilot study. Ultrasound Obstet Gynecol (2014) 1.45
The Yorkshire slide exchange external quality assessment (EQA) scheme. Cytopathology (1996) 1.45
BLOOD GROUP ACTIVITY OF GRAM-NEGATIVE BACTERIA. J Exp Med (1961) 1.44
Multiple systems for recognition of apoptotic lymphocytes by macrophages. Mol Biol Cell (1997) 1.44
Surface expression of phosphatidylserine on macrophages is required for phagocytosis of apoptotic thymocytes. Cell Death Differ (2000) 1.42
Beliefs that foster physician avoidance of psychosocial aspects of health care. J Fam Pract (1981) 1.42
A quantitative comparison of the sensitivity of serological test for bovine brucellosis to different antibody classes. J Hyg (Lond) (1976) 1.41
Involvement of spectrin in the maintenance of phase-state asymmetry in the erythrocyte membrane. Cell (1982) 1.40
Altered lipid packing identifies apoptotic thymocytes. Immunol Lett (1993) 1.33
Nucleosome structure, DNA folding, and gene activity. Cold Spring Harb Symp Quant Biol (1978) 1.32
Effects of incomplete pulmonary gas exchange on VO2 max. J Appl Physiol (1985) (1989) 1.31
Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood (1992) 1.30
Radioimmunoassay for antibodies against Brucella abortus: a new serological test for bovine brucellosis. J Hyg (Lond) (1976) 1.28
Engulfment of apoptotic cells involves the redistribution of membrane phosphatidylserine on phagocyte and prey. Nat Cell Biol (1999) 1.27
The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP. J Med Genet (1997) 1.26
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Technol Assess (2004) 1.26
History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder. J Affect Disord (2007) 1.25
Differential expression of putative transbilayer amphipath transporters. Physiol Genomics (1999) 1.23
Merocyanine 540, a fluorescent probe sensitive to lipid packing. Biochim Biophys Acta (1983) 1.22
Phospholipid asymmetry in human erythrocyte ghosts. J Cell Physiol (1985) 1.21
Oral-facial-digital syndrome type 1 is another dominant polycystic kidney disease: clinical, radiological and histopathological features of a new kindred. Nephrol Dial Transplant (1997) 1.20
Binding of merocyanine 540 to normal and leukemic erythroid cells. Cell (1980) 1.19
Coronary artery stents: a rapid systematic review and economic evaluation. Health Technol Assess (2004) 1.18
Coagulation changes in individuals with sickle cell trait. Am J Hematol (2002) 1.16
High intensity training-induced changes in skeletal muscle antioxidant enzyme activity. Med Sci Sports Exerc (1993) 1.15
Inequalities in outcomes of acute kidney injury in England. QJM (2012) 1.14
Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma. Ann Surg Oncol (2008) 1.14
Blood lactate disappearance at various intensities of recovery exercise. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.13
Transcription of histone-covered T7 DNA by Escherichia coli RNA polymerase. Biochemistry (1978) 1.13
Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. Proc Natl Acad Sci U S A (1988) 1.13
Assessment of painful episode frequency in sickle-cell disease. Am J Hematol (1997) 1.11
Effects of systemic demethylchlortetracycline on human cutaneous microflora. Appl Microbiol (1969) 1.11
Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. Arch Gen Psychiatry (1991) 1.10
Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst Rev (2004) 1.09
Incidence of exercise induced hypoxemia in elite endurance athletes at sea level. Eur J Appl Physiol Occup Physiol (1988) 1.09
Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect Immun (2000) 1.07
Comparison of the predictive power of different prognostic indices for overall survival in patients with advanced ovarian carcinoma. Cancer Res (1990) 1.07
Factors related to accuracy in office cholesterol testing. Iowa Academy of Family Physicians Research Network. J Fam Pract (1991) 1.06
Multiple members of a third subfamily of P-type ATPases identified by genomic sequences and ESTs. Genome Res (1998) 1.05
Does sodium hyaluronate- and carboxymethylcellulose-based bioresorbable membrane (Seprafilm) decrease operative time for loop ileostomy closure? Tech Coloproctol (2006) 1.04
The estimation of population microdata by using data from small area statistics and samples of anonymised records. Environ Plan A (1998) 1.03
The antimalarial activity of N-benzyl-oxydihydrotriazines. IV. The development of resistance to BRL 6231 (4,6-diamino-1,2-dihyydro-2-,2-dimethyl-1-(2,4,5-trichloropropyloxy)-1,3,5 triazine hydrochloride) by Plasmodium berghei. Ann Trop Med Parasitol (1982) 1.01
The state of maturation of monocytes into macrophages determines the effects of IL-4 and IL-13 on HIV replication. J Immunol (1997) 1.01
Pleomorphic adenoma and severe obstructive sleep apnoea. J Laryngol Otol (2005) 1.00
Alterations in chromatin structure during early sea urchin embryogenesis. Proc Natl Acad Sci U S A (1981) 0.99
Anthelmintic drugs for treating worms in children: effects on growth and cognitive performance. Cochrane Database Syst Rev (2000) 0.98
Silicone-induced hypercalcaemia in haemodialysis patients. Nephrol Dial Transplant (1987) 0.98
Phosphatidylserine vesicles inhibit phagocytosis of erythrocytes with a symmetric transbilayer distribution of phospholipids. Mol Membr Biol (1995) 0.98
Regulation of phosphatidylserine exposure and phagocytosis of apoptotic T lymphocytes. Cell Death Differ (1999) 0.98
Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev (2006) 0.97
Incipient neuroleptic malignant syndrome? Br J Psychiatry (1990) 0.97
Presence of human immunodeficiency virus DNA in laser smoke. Lasers Surg Med (1991) 0.96
Rapid loss and restoration of lipid asymmetry by different pathways in resealed erythrocyte ghosts. Biochim Biophys Acta (1992) 0.95
The serine-rich cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation. J Biol Chem (1993) 0.95
CD14 is a component of multiple recognition systems used by macrophages to phagocytose apoptotic lymphocytes. Cell Death Differ (1999) 0.95
Three syndrome concept of schizophrenia. A factor analytic study. Schizophr Res (1993) 0.95
Interleukin 8 and monocyte chemoattractant protein 1 production by cultured human airway smooth muscle cells. Cytokine (1998) 0.95
Stress and coping in first pregnancy: couple-family physician interaction. J Fam Pract (1981) 0.95
Dissatisfaction with consent for diagnostic gastrointestinal endoscopy. Dig Dis (2002) 0.94
Reconstitution of phospholipid scramblase activity from human blood platelets. Biochemistry (1996) 0.94
Bedside filtration of blood products in the prevention of HLA alloimmunization--a prospective randomized study. Alloimmunisation Study Group. Blood (1994) 0.94
Autocrine IL-1β-TRAF6 signalling promotes squamous cell carcinoma invasion through paracrine TNFα signalling to carcinoma-associated fibroblasts. Oncogene (2012) 0.94
Membrane phospholipid asymmetry as a factor in erythrocyte-endothelial cell interactions. J Cell Physiol (1985) 0.93
Clinical economics review: medical management of inflammatory bowel disease. Aliment Pharmacol Ther (1999) 0.91
A functional genomics approach to evaluate candidate genes located in a QTL interval for milk production traits on BTA6. Anim Genet (2009) 0.91
Falling incidence of HIV infection in a cohort of clinic attenders. Aust J Public Health (1993) 0.90
Accuracy of pulse oximetry to estimate HbO2 fraction of total Hb during exercise. J Appl Physiol (1985) (1989) 0.90
Mechanisms for recognition and phagocytosis of apoptotic lymphocytes by macrophages. Adv Exp Med Biol (1996) 0.90
A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Curr Med Chem (2009) 0.90
Dangers of cocaine and adrenaline paste. Accurate measurement of dose and patience are important. BMJ (1995) 0.90
Identification and chromosomal mapping of a third mouse runt-like locus. Genomics (1995) 0.89